By proceeding, you agree to our Terms of Use and Privacy Policy.
Panna Sharma is the President, CEO, and Board Member of Lantern Pharma Inc., a clinical-stage oncology biotech using artificial intelligence (AI) and genomics to innovate the rescue, revitalization, and development of precision cancer therapeutics.
Talks About #genomics #aihealthcare #biotechnology #cancerresearch #teamdevelopment
Preferred Locations #NorthAmerica
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail & AstraZeneca, Amgen & Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift.